DATA FORM FOR CANCER STAGING - URETHRA
Form # 785-1-049
| CLIN | PATH | DEFINITIONS | |
| PRIMARY TUMOR (T) | |||
| TX | Primary tumor cannot be assessed | ||
| T0 | No evidence of primary tumor | ||
| Ta | Noninvasive papillary, polypoid, or verrucous carcinoma | ||
| Tis | Carcinoma in situ | ||
| T1 | Tumor invades subepithelial connective tissue | ||
| T2 | Tumor invades corpus spongiosum or prostate or periutheral muscle | ||
| T3 | Tumor invades corpus cavernosum or beyond prostatic capsule or the anterior vagina or bladder neck | ||
| T4 | Tumor invades other adjacent organs | ||
| LYMPH NODE (N) | |||
| NX | Regional lymph nodes cannot be assessed | ||
| N0 | No regional lymph node metastasis | ||
| N1 | Metastasis in single lymph node, 2 cm or less in greatest dimension | ||
| N2 | Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension, or multiple lymph nodes, none more than 5 cm in greatest dimension | ||
| N3 | Metastasis in a lymph node more than 5 cm in greatest dimension | ||
| DISTANT METASTASIS (M) | |||
| MX | Presence of distant metastasis cannot be assessed | ||
| M0 | No distant metastasis | ||
| M1 | Distant metastasis | ||
| CLIN | PATH | STAGE GROUPING | |||
| 0a | Ta | N0 | M0 | ||
| 0is | Tis | N0 | M0 | ||
| I | T1 | N0 | M0 | ||
| II | T2 | N0 | M0 | ||
| III | T1 | N1 | M0 | ||
| T2 | N1 | M0 | |||
| T3 | N0 | M0 | |||
| T3 | N1 | M0 | |||
| IV | T4 | N0 | M0 | ||
| T4 | N1 | M0 | |||
| Any T | N2 | M0 | |||
| Any T | N3 | M0 | |||
| Any T | Any N | M1 | |||
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| Comments: |
| Patient Name: |